JUVEDERM ULTRA PLUS XC 93900Recalls & reported problems
Allergan, Inc. · Juvederm Ultra PLUS XC 27G 2x0.4mL · Class 3 · Implant
All models of JUVEDERM ULTRA PLUS XC (2)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10888628000100), received between Oct 30, 2017 and Oct 24, 2018 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Detachment Of Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Detachment Of Device Component2
- Detachment of Device or Device Component2
- Leak/Splash2
- Burst Container or Vessel1
- Crack1
- Difficult or Delayed Positioning1
- Expulsion1
- Use of Device Problem1
Patient problems
- No Known Impact Or Consequence To Patient4
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 24, 2018Detachment of Device or Device Component; Detachment of Device or Device Component
HEALTHCARE PROFESSIONAL REPORTED 1 SYRINGE OF JUVÉDERM® ULTRA PLUS XC HAD ¿THE NEEDLE POP OFF AS IT WAS BEING PULLED OUT OF THE PATIENT¿S FACE.¿ PATIENT CONTACT WAS MADE, BUT NO INJURY TO PATIENT, STAFF, OR INJECTOR. INJECTOR USED A 30G ALLERGAN NEEDLE INSTEAD OF THE 27G ONE THAT CAME WITH THE SYRINGE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8003176 ↗MalfunctionMay 24, 2018Detachment Of Device Component; Difficult or Delayed Positioning; Expulsion; Detachment Of Device Component; Difficult or Delayed Positioning; Expulsion
HEALTHCARE PROFESSIONAL REPORTED ONE SYRINGE OF JUVÉDERM® ULTRA PLUS XC HAD AN ISSUE WITH PRODUCT NOT PASSING THROUGH SYRINGE DURING INJECTION. THE PHYSICIAN CHANGED THE NEEDLE TO ANOTHER ALLERGAN NEEDLE FROM THE SAME BOX. PRODUCT STILL WOULD NOT PASS, THEN POPPED THE NEEDLE OFF AND SPILLED OVER TRAY. NO PATIENT CONTACT WAS MADE. NO INJURIES WERE REPORTED. BOTH PACKAGED NEEDLES WERE USED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7541146 ↗MalfunctionFeb 16, 2018Detachment Of Device Component; Leak/Splash; Detachment Of Device Component; Leak/Splash
HEALTHCARE PROFESSIONAL REPORTED DURING INJECTION WITH JUVÉDERM® ULTRA PLUS XC THE PRODUCT "STARTED COMING OUT WHERE THE NEEDLE ATTACHES TO THE SYRINGE." PATIENT CONTACT WAS MADE, BUT NO INJURY TO PATIENT, STAFF, OR INJECTOR. THE PACKAGED NEEDLE WAS USED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7278680 ↗MalfunctionDec 28, 2017Crack; Use of Device Problem; Detachment of Device or Device Component; Crack; Use of Device Problem; Detachment of Device or Device Component
HEALTHCARE PROFESSIONAL REPORTED THE EVENT OF DURING PATIENT INJECTION WITH ONE SYRINGE OF JUVÉDERM® ULTRA PLUS XC THE NEEDLE DISENGAGED, THE LUER LOCK CRACKED, AND PRODUCT SPILLED OUT AT THE LUER LOCK. PATIENT CONTACT WAS MADE. NO INJURY TO THE PATIENT OR INJECTOR WAS REPORTED. THE NEEDLE FROM THE PACKAGE WAS USED. THIS WAS THE INITIAL USE OF THE SYRINGE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7151106 ↗MalfunctionOct 30, 2017Burst Container or Vessel; Leak/Splash; Burst Container or Vessel; Leak/Splash
HEALTHCARE PROFESSIONAL REPORTED THE EVENT OF THAT DURING INJECTION, ONE SYRINGE OF JUVÉDERM® ULTRA PLUS XC "BUSTED" WHERE THE NEEDLE SCREWS ON AND THE INJECTOR "LOST ALL THE FILLER". PATIENT CONTACT WAS MADE. NO INJURY TO THE PATIENT, INJECTOR OR STAFF REPORTED. THE PACKAGED NEEDLE WAS USED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6988408 ↗
Other Implant, Dermal, For Aesthetic Use devices
- JUVEDERM VOLUMA XC 94640Allergan, Inc. · Implant, Dermal, For Aesthetic Use672 reports
- JUVEDERM ULTRA XC 94154Allergan, Inc. · Implant, Dermal, For Aesthetic Use541 reports
- JUVEDERM VOLLURE XC 95661Allergan, Inc. · Implant, Dermal, For Aesthetic Use380 reports
- JUVEDERM ULTRA PLUS XC 94155Allergan, Inc. · Implant, Dermal, For Aesthetic Use319 reports
- JUVÉDERM VOLBELLA XC 95834Allergan, Inc. · Implant, Dermal, For Aesthetic Use187 reports
- Skinvive 98307Allergan, Inc. · Implant, Dermal, For Aesthetic Use183 reports
- Revanesse Lips+ with Lidocaine 1.2 mL 40149Prollenium Medical · Implant, Dermal, For Aesthetic Use72 reports
- Radiesse (+) Lidocaine 8063M0K2Merz North America, Inc. · Implant, Dermal, For Aesthetic Use61 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page